Search the Newsreel

Inspire Medical Systems (NYSE: INSP) director receives 581-share stock fee award

Inspire Medical Systems director Gary Lee Ellis was awarded 581 shares of common stock on July 15, 2026, as compensation in lieu of cash fees, with a stated price of $0.0000 per share. Following this grant, Ellis directly holds 11,419 shares of the company's …

Form 4 Inspire Medical Systems Inc For: 17 July By Investing.com

This article from Investing.com is a standard financial announcement about a Form 4 filing for Inspire Medical Systems Inc (INSP) on July 17. The core content is minimal, serving primarily as a brief notification of the filing. It includes a reference to Reuters and …

ETFs Investing in Inspire Medical Systems, Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Inspire Medical Systems, Inc. stocks, providing financial data for each. The funds are primarily small-cap oriented, managed by major financial institutions like BlackRock, Vanguard, and State Street. The information includes market value, weight of …

Here's Why You Should Retain INSP Stock in Your Portfolio for Now

Inspire Medical Systems (INSP) is facing challenges primarily related to coding and reimbursement uncertainty for its Inspire V procedures, which is impacting revenue and procedure volumes despite strong clinical innovation and regulatory expansion. The company is navigating issues with the WISeR authorization program and …

What Insperity (NSP)'s HRScale Workday Partnership Means For Shareholders

Insperity's new HRScale partnership with Workday aims to target the mid-market segment and blend advanced HR software with bundled services, potentially reshaping its business mix and improving operating efficiency. While this collaboration is a key near-term catalyst for the company's earnings recovery, the biggest …

Truist Adjusts Price Target on Inspire Medical Systems to $54 From $50, Maintains Hold Rating

Truist has increased its price target for Inspire Medical Systems (NYSE:INSP) to $54 from $50, while reiterating a "Hold" rating on the stock. The medical technology company, which focuses on solutions for obstructive sleep apnea, was also recently added to several Russell indices. Inspire …

Insperity (NSP) Gains On HRScale Hopes, Is The Stock Above Fair Value?

Insperity (NSP): Buy, Sell, or Hold Post Q1 Earnings?

Inspired Entertainment Q1 2026 Earnings: Narrower-than-Expected Loss Drives Modest Stock Gain - High Growth Earnings

Inspired Entertainment (INSE) Is Attractively Priced Despite Fast-paced Momentum

Inspired (INSE): Buy, Sell, or Hold Post Q1 Earnings?

InspireMD Inc. (NSPR) Gains Momentum: Breaking Above Key Support - Market Leader Picks

EARNINGS AND TRADING: Inspecs strikes eyewear pact with Qualcomm

Q1 Earnings Highs And Lows: Insperity (NYSE:NSP) Vs The Rest Of The Professional Staffing & HR Solutions Stocks

Inspired Entertainment: Still Mooing, Still Mispriced (NASDAQ:INSE)

InspireMD Inc. (NSPR) Q1 2026 Earnings: Narrower Loss Than Expected But Shares Slide - Return On Capital

Inspired Entertainment (INSE) Tests Support After 1.3% Decline - Blue Chip Entry Points

Earnings call transcript: Inspired Entertainment Q1 2026 earnings beat expectations

Inspecs maintains stable revenue while restructuring operations as takeover bid becomes unconditional (SPEC)

As it prepares to go private, InSpecs results show impact of tough backdrop - FashionNetwork

Things Look Grim For Inspire Medical Systems, Inc. (NYSE:INSP) After Today's Downgrade

Inspirisys Solutions consolidated net profit declines 28.47% in the March 2026 quarter

Inspirisys Solutions Reports Audited FY26 Financial Results; Revenue Rises

Insperity Q1 Earnings Beat Estimates on Margin Recovery

Inspired Reports First Quarter 2026 Results

Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why

Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down

InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates

Earnings call transcript: InspireMD beats Q1 2026 forecasts but faces operational pause

Inspire Medical Systems’s (NYSE:INSP) Q1 CY2026 Sales Top Estimates But Stock Drops 18.8%

Inspire (INSP) Reports Q1 Earnings: What Key Metrics Have to Say

INSP Q1 Deep Dive: Coding Headwinds and WISER Program Drive Down Full-Year Outlook

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Insperity (NSP) Is Down 12.9% After Cut To 2026 Earnings Outlook Amid Margin Pressures

Inspire Medical Systems (INSP) To Report Earnings Tomorrow: Here Is What To Expect

Insperity, Inc. (NYSE:NSP) First-Quarter Results: Here's What Analysts Are Forecasting For This Year